<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The endothelium plays an important role in the regulation of the intracellular fluid, vascular permeability, and modulation of vascular focal tone and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">Endothelial dysfunction</z:e> is manifested by the loss of the endothelium ability to modulate <z:mp ids='MP_0001532'>physiology</z:mp> changes in its vascular bed, and actually it is considered a prognostic marker of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The relevance of assessing <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> relies in that it has been observed in different pathologies like DM, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, tabaquism and in <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immunologic diseases</z:e> like <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>PET is a non invasive method that allows the absolute quantification of myocardial blood flow during rest, stress and adrenergic stimulation, which allows to asses endothelial function </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore PET is a useful diagnostic technique to identify patients with <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, and in the assessment of its response to administered therapy, allowing an optimal control and prevention of secondary adverse events of these diseases </plain></SENT>
</text></document>